Patent · US Active

Liquid buffered GDF-5 formulations

US7947649B2 · kind B2 · utility

8Cited by
66References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 8, 2009
Grant dateMay 24, 2011
Priority date
Expiry dateApr 26, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P19/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Improved formulations and methods are provided for stabilizing a solution of bone morphogenetic protein. The compositions comprise an acetate buffered solution of GDF-5 and other excipients wherein the solution has a pH of from about 4.2 to about 5.3, thereby providing for a biologically isotonic solution having improved stability of the GDF-5 protein during storage, handling, and use.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.